Assessment of efficacy and safety for a new wound dressing URGO 310 3166 in the local treatment of venous or mixed leg ulcers: a european, randomised clinical trial - CLEANER

aboratoires URGO0 个研究点目标入组 220 人开始时间: 2015年11月9日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Patient over 18 years old who has provided his/her written informed consent,
•Patient who can be monitored by the same investigation team throughout the whole duration of the study,
•Patient who agrees to wear an effective venous compression system every day, associated with the trial dressing,
•Leg ulcer with an Ankle Brachial Pressure Index (ABPI) not less than 0.7 and not more than 1.3,
•Ulcer area Superior or equal to 5 cm2,
•Ulcer duration Superior or equal to 6 months,
•Ulcer presenting a the surface wound bed covered with 50% or more by sloughy tissue,
•Moderately or heavly exudative ulcers.

发起方

aboratoires URGO